Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Sequire Spotlight Presents: Biostem (BSEM) – Harnessing the Natural Properties of Placenta Tissues

Host Chris Miglino interviews CEO Jason Matuszewski. He talks about their product, the way that it’s produced, recovered, proccessed, and the way that it supports bodies to recover from wounds.

Biotechnology
November 20, 2024

Related Videos

Related Posts

Related Videos

Sequire Spotlight Presents: BioHarvest Sciences (BHST) – Global Leader in Plant Cell Technology December 03, 2024
Sequire Spotlight Presents IGC Pharma (IGC): A Focus on Alzheimer’s Molecules August 22, 2023
Sequire Spotlight Presents Equillium Inc (EQ): Leaders in the Field of Immunobiology August 22, 2023
Sequire Spotlight Presents PetVivo Holdings, Inc. (PETV): Adapting Human Biotech Into The Veterinary Industry. November 09, 2022
Sequire Spotlight Presents Lexaria Bioscience (LEXX): Bringing Vitamin Delivery to the Next Level September 19, 2022
Sequire Spotlight Presents Nexgel, Inc. (NXGL): Beauty Harnessed From Water June 17, 2022
Sequire Spotlight Presents Chromadex (CDXC): Unleashing the Guarded Secret to Better Aging June 17, 2022
Sequire Spotlight presents Banxa Holdings (BNXAF): The Bridge Between Fiat and Crypto February 02, 2022
Sequire Spotlight Presents BranchOut Food Inc. (BOF): Nourishing the Future with Sustainable Plant-Based Foods October 28, 2023
Sequire Spotlight presents Ideanomics (IDEX): Powering The Sustainable Future Of Transportation November 10, 2021

Related Post

OS Therapies Announces Positive Data for OST-HER2 in the Treatment of Unresected Osteosarcoma in Dogs Opening the Potential for Use as Front-Line Therapy in Humans

April 10, 2025
OS Therapies Agrees to Acquire All Listeria Monotygenes-based Immuno-Oncology Programs and IP Assets from Ayala Pharmaceuticals, Adding Phase 2 Lung Cancer and Phase 1 Prostate Cancer Programs to Pipeline

January 29, 2025
HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma

January 14, 2025
Athira Pharma: Advancing Bold Therapies for Neuronal Health

July 16, 2024

Microcaps.com is a trademark of SRAX, Inc.

Privacy Policy
Cookie Policy
Contact Us

About SRAX
About Sequire

We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.